NEW YORK (GenomeWeb News) – Berlin-based RiNA has acquired Roche Applied Science's RTS Protein Expression portfolio of cell-free expression kits for an undisclosed sum, Roche said today.
Under the agreement, which takes effect Sept. 15, the firm 5 Prime will serve as RiNA's distributor for the kits, Roche said.
Manfred Baier, who is head of Roche Applied Science, said in a statement that "a company specializing in proteomics will be able to develop the potential of RTS technology much faster than we can."